Comparing quality measures during hospitalization for chronic obstructive pulmonary disease in 2005-06 and 2010

C. P. Aaron, N. H. Yip, M. D. Brinson, E. Lazar, B. Regan, L. George, M. S. Melamed, P. Sachs, M. Daley, B. M. Thomashow (New York, United States Of America)

Source: International Congress 2014 – Respiratory disease within hospital-based populations
Session: Respiratory disease within hospital-based populations
Session type: Thematic Poster Session
Number: 4109
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. P. Aaron, N. H. Yip, M. D. Brinson, E. Lazar, B. Regan, L. George, M. S. Melamed, P. Sachs, M. Daley, B. M. Thomashow (New York, United States Of America). Comparing quality measures during hospitalization for chronic obstructive pulmonary disease in 2005-06 and 2010. Eur Respir J 2014; 44: Suppl. 58, 4109

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013


Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Economic effectiveness of integrated care model (ICM) for patients with severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics
Source: International Congress 2015 – Different data in COPD
Year: 2015

Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014

Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013